纳米标准与检测重点实验室第335期学术报告

报告题目：Trust, peer review, and impact 

报  告 人：Pep Pàmies 

时     间：2025年6月24日（星期二）下午14：00

地     点：国家纳米科学中心 新楼第六会议室

主 持 人：聂广军 研究员  孙佳姝 研究员

报告内容：

In this discussion, Pep will convey the role of selective journals in accelerating research, and provide examples of how journals can drive meaningful changes in peer review, steer communities toward sharing protocols, data and code, and help build trust in careful science reporting. He will argue that leading bioengineering journals should showcase the value that they provide to the communities they serve, empower researchers to help them advance discovery and technology for improving human health, and actively guide research communities toward better reporting standards, increased openness, more valuable scientific outputs and stories, and the most promising technological and translational solutions.

报告人简介：

Pep Pàmies founded Nature Biomedical Engineering — a journal from the Nature family that launched in January 2017 — and led its editorial team for 9 years. Pep steered Nature Biomedical Engineering to emphasize translational utility over raw novelty, robustness over superficial impressiveness, and the nuanced reporting of findings and their implications. He developed influential review and opinion content, and championed technology for diagnostics, genome editing, cell engineering, drug delivery, single-cell omics and machine learning across a swath of disease areas (most prominently, immuno-oncology, genetic diseases, cardiorespiratory disorders and infectious diseases). Before he launched Nature Biomedical Engineering, Pep was an editor for Nature Materials for more than 5 years. Previously, Pep conducted research in computational soft matter and biophysics at Columbia University's Chemistry Department in New York City, at the Max Planck Institute of Colloids and Interfaces in Potsdam, and at the Atomic and Molecular Physics Institute in Amsterdam. Pep obtained a PhD in Chemical Engineering from Rovira i Virgili University in Catalonia, Spain.